| Improving patient self-care using diabetes technologies V Alcántara-Aragón Therapeutic advances in endocrinology and metabolism 10, 2042018818824215, 2019 | 65 | 2019 |
| Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases LS Gomez-Guerra, ML Martinez-Fierro, V Alcantara-Aragon, ... BMC cancer 9, 1-6, 2009 | 55 | 2009 |
| Thyroglobulin as early prognostic marker to predict remission at 18–24 months in differentiated thyroid carcinoma C González, A Aulinas, C Colom, D Tundidor, L Mendoza, R Corcoy, ... Clinical endocrinology 80 (2), 301-306, 2014 | 37 | 2014 |
| PREDIRCAM eHealth Platform for Individualized Telemedical Assistance for Lifestyle Modification in the Treatment of Obesity, Diabetes, and Cardiometabolic Risk Prevention: A … C González, P Herrero, JM Cubero, JM Iniesta, ME Hernando, ... Journal of diabetes science and technology 7 (4), 888-897, 2013 | 23 | 2013 |
| Carbohydrate-to-insulin ratio in a Mediterranean population of type 1 diabetic patients on continuous subcutaneous insulin infusion therapy V Alcántara-Aragón, C Gonzalez, R Corcoy, J Ubeda, A Chico Journal of diabetes science and technology 9 (3), 588-592, 2015 | 20 | 2015 |
| Severe ectopic cushing syndrome caused by adenoid cystic carcinoma of a salivary gland V Alcantara, E Urgell, JF Sancho, A Chico Endocrine Practice 19 (5), e118-e121, 2013 | 6 | 2013 |
| Web support for weight-loss interventions: PREDIRCAM2 clinical trial baseline characteristics and preliminary results V Alcántara-Aragón, S Rodrigo-Cano, A Lupianez-Barbero, MJ Martinez, ... Diabetes Technology & Therapeutics 20 (5), 380-385, 2018 | 5 | 2018 |
| Genetic analysis does not confirm non-classical congenital adrenal hyperplasia in more than a third of the women followed with this diagnosis V Alcantara-Aragon, S Martinez-Couselo, D Tundidor-Rengel, SM Webb, ... Hormones 13 (4), 585-587, 2014 | 2 | 2014 |
| Crisis comicial en paciente diabética.¿ Hipoglucemia o efecto secundario de la monitorización continua de glucosa? V Alcántara, JM Cubero, A Prados, J Pérez Pérez, R Corcoy Endocrinología y Nutrición 59 (2), 144-146, 2012 | 1 | 2012 |
| Seizure in a diabetic patient. Hypoglycemia or a side effect of continuous glucose monitoring? V Alcántara, JM Cubero, A Prados, R Corcoy Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia …, 2011 | 1 | 2011 |
| CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 1 DIABETES MELLITUS WHO FOLLOW INSULIN PUMP THERAPY AT THE MARQUES DE VALDECILLA UNIVERSITY HOSPITAL L Aizpeolea San Miguel, M Piedra, R Batanero, V Alcantara Aragon, ... DIABETES TECHNOLOGY & THERAPEUTICS 24, A13-A13, 2022 | | 2022 |
| Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes BF Rodriguez Montalvan, V Alcantara Aragon, M Piedra Leon, ... Diabetes research and clinical practice, 109390-109390, 2022 | | 2022 |
| Social media use in an obesity intervention-Results from the PREDIRCAM2 study. V Alcántara-Aragón, S Rodrigo-Cano, A Lupiañez, J Tapia, J Iniesta, ... Endocrinology 1 (4), 5, 2019 | | 2019 |
| Using diabetes technologies to improve patient self care V Alcantara-Aragon Endocrine Abstracts 56, 2018 | | 2018 |
| Telematic monitorization and intensification for life style modification as a treatment for obesity and cardiometabolic risk prevention V Alcántara Aragón | | 2018 |
| Intensified telematic treatment for obesity-drop out rates and predictors at 6 months of PREDIRCAM2 web intervention V Alcántara Aragón, S Rodrigo Cano, A Lupiañez, J Tapia Galisteo, ... Telecomunicacion, 2018 | | 2018 |
| Intensified telematic treatment for obesity using the web platform PREDIRCAM2, descriptive basal characteristics and preliminary results V Alcantara-Aragon, S Rodrigo-Cano, MJ Martinez, C Martinez, J Tapia, ... Endocrine Abstracts 49, 2017 | | 2017 |
| Proyecto PREDIRCAM 2. Análisis preliminar de uso y valoración de la plataforma J Tapia, JM Iniesta Chamorro, V Alcántara Aragón, S Rodrigo Cano, ... Universidad del País Vasco, 2017 | | 2017 |
| PREDIRCAM 2. Plataforma Tecnológica para la Prevención de la Diabetes Tipo 2 y el Riesgo CardioMetabólico J Tapia, JM Iniesta, V Alcántara, G García-Sáez, G Navarro, C González, ... LIBRO DE ACTAS 3, 121, 2015 | | 2015 |
| Carbohydrate-to-insulin ratio in type 1 diabetic patients treated with continuous subcutaneous insulin infusion therapy (CSII) C Gonzalez, I Orellana, R Corcoy, V Alcantara, A Chico DIABETOLOGIA 56, S444-S444, 2013 | | 2013 |
